Jamie L. Reynoso - 14 Jun 2023 Form 4 Insider Report for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

Role: CEO of Medicare Advantage
Signature: /s /Scott Leffler, as attorney-in-fact for Jamie L. Reynoso
Issuer symbol: CLOV
Transactions as of: 14 Jun 2023
Net transactions value: -$7,309
Form type: 4
Filing time: 16 Jun 2023, 16:04:15 UTC
Previous filing: 05 Jan 2023
Next filing: 03 Jan 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CLOV	Class A Common Stock	Tax liability	$7,309	-7,776	-0.56%	$0.9400	1,380,885	14 Jun 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on June 16, 2023, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on March 14, 2022, and timely reported on a Form 4 filed on March 16, 2022. The remaining RSUs will vest quarterly in equal installments of 6.25%, with the final vesting date occurring on March 17, 2026, subject to the continued service of the Reporting Person on each such vesting date.

Content

Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on June 16, 2023, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on March 14, 2022, and timely reported on a Form 4 filed on March 16, 2022. The remaining RSUs will vest quarterly in equal installments of 6.25%, with the final vesting date occurring on March 17, 2026, subject to the continued service of the Reporting Person on each such vesting date.